B1680

Bradyzide di(trifluoroacetate) salt hydrate

≥98%

• 동의어(들): (S)-1-[4-(4-Benzhydrylthiosemicarbazido)-3-nitrobenzenesulfonyl]-pyrrolidine-2-carboxylic acid [2-[(2-dimethylaminoethyl)methylamino]ethyl] amide
• 실험식(Hill 표기법): C₃₂H₄₂N₈O₅S₂ · 2C₂HF₃O₂ · xH₂O
• Molecular Weight: 910.90 (anhydrous basis)
• MDL number: MFCD02684401
• UNSPSC 코드: 41106200
• NACRES: NA.32

속성

• Quality Level: 100
• 분석: ≥98%
• 양식: solid
• solubility: H₂O: >40 mg/mL
• 저장 온도: −20°C

설명

생화학적/생리학적 작용

Potent, orally active, non-peptide B₂ bradykinin receptor antagonist.

특징 및 장점

This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

안전성 정보

• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable
• 개인 보호 장비: Eyeshields, Gloves, type N95 (US)